{"anticipatedPostingDate":"2027-10","denomUnitsSelected":"Participants","description":"Progression free survival will be assessed as the time interval from the end of the Phase 3 study until death, withdrawal of consent, study termination, or until a subject is lost to follow-up. As per IWG criteria disease progression is defined as: at least one of the following: at least 50 percent (%) decrement from maximum response levels in granulocytes or platelets; reduction in hemoglobin by greater than or equal to ≥1.5 g/dL; transfusion dependence.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 3 years in the extension phase","title":"Extension Phase: Progression Free Survival (PFS) Survival","type":"OTHER_PRE_SPECIFIED"}